American Journal of Ophthalmology
Volume 139, Issue 5 , Pages 920-921, May 2005

Corneal Tattooing for the Treatment of Debilitating Glare in a Child With Traumatic Iris Loss

  • Arif O. Khan, MD

      Affiliations

    • Department of Pediatric Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
    • Corresponding Author InformationInquiries to Arif O. Khan, MD, Consultant Pediatric Ophthalmologist, King Khaled Eye Specialist Hospital, P.O. Box 7191, Riyadh, 11462, Saudi Arabia; fax: 966 01 482 9311
  • ,
  • David Meyer, MB ChB, PhD

      Affiliations

    • Department of Oculoplastic Surgery, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
    • Department of Ophthalmology, Faculty of Health Sciences, University of Stellenbosch, Tygerberg, South Africa.

Accepted 18 October 2004.

Purpose

To report the cosmetic and therapeutic use of corneal tattooing for a child with sectoral traumatic corneal scarring and symptomatic glare from sectoral traumatic iris loss.

Design

Interventional case report.

Methods

A six-year-old girl underwent corneal tattooing (platinum chloride reduced by hydrazine) in the relevant scarred corneal sector.

Results

Six months after the procedure, the child enjoyed a more normal corneal appearance and no longer suffered from glare. Postoperative epithelial healing, however, was slow and required vigilance.

Conclusions

Corneal tattooing can allow both cosmetic and therapeutic benefit when indicated in a child. However, postoperative healing may require management when using platinum chloride reduced by hydrazine.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(04)01294-2

doi:10.1016/j.ajo.2004.10.048

American Journal of Ophthalmology
Volume 139, Issue 5 , Pages 920-921, May 2005